Obstructive sleep apnea (OSA) commonly occurs in patients with increased cardiovascular
(CV) risk, and continuous positive airway pressure (CPAP) is the preferred therapy for these …

Aims To assess whether continuous positive airway pressure (CPAP) therapy reduces major
adverse cardiovascular events (MACE) in patients with moderate-to-severe obstructive …

Purpose Continuous positive airway pressure (CPAP) therapy may decrease the risk of
mortality and cardiovascular events in patients with obstructive sleep apnea. However, these …

Background It remains uncertain whether continuous positive airway pressure (CPAP)
therapy would significantly impact hard clinical outcomes in patients with obstructive sleep …

Background Obstructive sleep apnea (OSA) is highly prevalent in patients with coronary
artery disease (CAD) and is associated with recurrent cardiovascular risk. However, whether …

Obstructive sleep apnea (OSA) is associated with increased cardiovascular morbidity and
mortality. Continuous positive airway pressure (CPAP) is the main treatment of OSA. The …

Purpose The associations between obstructive sleep apnea (OSA) and all-cause and
cardiovascular mortality are well established but are not entirely consistent. To accurately …

Background Obstructive sleep apnea is associated with an increased risk of cardiovascular
events; whether treatment with continuous positive airway pressure (CPAP) prevents major …

Importance The effect of continuous positive airway pressure (CPAP) on secondary
cardiovascular disease prevention is highly debated. Objective To assess the effect of CPAP …

Obstructive sleep apnea (OSA) is associated with cardiovascular risk factors, cardiovascular
diseases, and increased mortality. Epidemiological studies have established these …